Recommended for his Capital Markets and Transactional Telecoms & Broadcast practices.The Legal 500 US 2014-2017

Jason M. Licht

New York | Washington, D.C.
  • 885 Third Avenue
  • New York, NY 10022-4834
  • USA

Jason Licht is a partner in the Washington, D.C. and New York offices of Latham & Watkins, local Co-Chair of the Corporate Department in the Washington, D.C. office, and Global Vice Chair of the Private Equity Finance Practice. Mr. Licht has significant experience in capital markets transactions, general corporate and securities matters, and public company representation. Mr. Licht previously served as a member of the firm's Associates Committee.

Mr. Licht regularly represents public and private companies, private equity sponsors, and investment banks in capital markets transactions, including in connection with initial public offerings and financings for leveraged buyout and acquisition transactions. 

He also represents both public and private companies regarding their equity and debt offerings, reporting obligations, and corporate governance matters in various industries, including: 

  • Technology
  • Aerospace
  • Transportation
  • Communications
  • Manufacturing

Mr. Licht’s recent experience includes advising: 

  • CommScope Holdings in its US$576 million IPO and numerous secondary offerings and debt financings, including in connection with the acquisition of ARRIS, the Broadband Network Solutions (BNS) business unit of TE Connectivity Ltd.
  • MultiPackaging Solutions in its US$246 million IPO and secondary offering
  • Allison Transmission Holdings in its US$690 million IPO, numerous secondary offerings and offering of senior notes
  • Wesco Aircraft Holdings in its US$315 million IPO and secondary offerings
  • The underwriters in the IPOs of:
    • PPD, Inc. (US$1.8 billion)
    • PQ Group Holdings (US$508 million)
    • Blue Buffalo Pet Products (US$778 million)
    • K2M Group Holdings (US$147 million)
    • Booz Allen Hamilton (US$273 million)
    • Mako Surgical Corp. (US$51 million)
    • Vitamin Shoppe (US$154 million)
  • The Carlyle Group in numerous acquisition financings and securities offerings, including in the acquisition of Standard Aero, Nouryon, Atotech, Veritas, Acosta, Ortho Clinical Diagnostics, Axalta, NBTY, Sequa Corporation, Open Solutions
  • Leonard Green & Partners and Ares Corporate Opportunity Fund in the senior secured second lien notes offering to finance the acquisition of Press Ganey
  • Cinven in the senior secured second lien notes offering to finance the acquisition of Jaggaer
  • Ares Management and another investor in the senior notes and senior PIK toggle notes to finance the acquisition of Neiman Marcus Group
  • BC Partners and The Carlyle Group in the senior notes offering to finance the acquisition of Accudyne (Hamilton Sundstrand Industrial)
  • The Carlyle Group and Hellman & Friedman in the senior notes offering to finance the acquisition of Pharmaceutical Product Development (PPD)
  • The Carlyle Group and Onex Corporation in the senior notes offerings to finance the acquisition of Allison Transmission Holdings
  • KKR in connection with the financing of the acquisition of Capital Safety
  • Platinum Equity and Nesco in the offering of senior secured second lien notes
  • Energy Transfer Equity in connection with the financing for the acquisition of Southern Union Company
  • Riverstone in the debt financings of Hudson Products
  • PQ Corporation in its offering of second lien senior secured notes
  • PPD in its offerings of senior notes and dividend holdco PIK notes
  • NBTY in its offerings of senior notes and dividend holdco PIK notes
  • Zekelman Industries (formerly JMC Steel Group) in its offerings of senior notes 
Thought Leadership
  • The Latham US IPO Guide
  • Declining Market Capitalizations and the Impairment of Goodwill
  • Navigating Debt Repurchases - Issues and Answers
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.